Pharmacological characterization of a new 4-amidinophenylalanine thrombin-inhibitor (CRC 220)

Author： Dickneite G. Diehl K.H. Reers M. Czech J. Weinmann E. Hoffmann D. Stuber W. Seiffge D.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.77, Iss.4, 1995-02, pp. : 357-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombin-inhibitor complexes in the blood during and after delivery

By Andersson T. Mowinckel M.-C. Abildgaard U. Lorentzen B. Hogdahl H. Clausen T.

Thrombosis Research, Vol. 82, Iss. 2, 1996-04 ,pp. : 109-117

Elsevier

Access to resources Recommend Favorite

Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673

By Chu V. Brown K. Colussi D. Gao J. Bostwick J. Kasiewski C. Bentley R. Morgan S. Guertin K. Pauls H.W. Gong Y. Zulli A. Perrone M.H. Dunwiddie C.T. Leadley R.J.

Thrombosis Research, Vol. 103, Iss. 4, 2001-08 ,pp. : 309-324

Elsevier

Access to resources Recommend Favorite

Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor

By Yokono Masanori

Endocrine Research, Vol. 38, Iss. 3, 2013-08 ,pp. : 168-183

Informa Healthcare

Access to resources Recommend Favorite

Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor

By Mendes-Silva W. Assafim M. Ruta B. Monteiro R.Q. Guimaraes J.A. Zingali R.B.

Thrombosis Research, Vol. 112, Iss. 1, 2003-01 ,pp. : 93-98

Elsevier

Access to resources Recommend Favorite

Inhibition of neointimal hyperplasia by a specific thrombin inhibitor

By Wahlgren Carl-Magnus Frebelius Siw Swedenborg Jesper

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 1, 2004-02 ,pp. : 16-21

Informa Healthcare

Access to resources Recommend Favorite